3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Specimen Handling
34
Carboplatin
32
pembrolizumab
28
Pemetrexed
27
Magnetic Resonance Spectroscopy
27
Cisplatin
22
Paclitaxel
15
Gemcitabine
13
durvalumab
12
Docetaxel
12
osimertinib
11
Nivolumab
11
atezolizumab
8
Immunoglobulin G
8
Disulfides
8
Taxes
7
Etoposide
7
130-nm albumin-bound paclitaxel
7
Radiotherapy
6
Radiosurgery
6
Radiation
6
Platinum
6
Cetuximab
6
Biopsy
6
X-Rays
5
1,2-diaminocyclohexaneplatinum II citrate
5
Ramucirumab
4
Observation
4
Irinotecan
4
Albumin-Bound Paclitaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.